Try our mobile app

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Danaher Corporation designs, manufactures, and markets professional, medical, industrial and commercial products, and services in the sectors of test and measurement, environmental, life sciences, dental, and industrial technologies.
Website: danaher.com


  • Good financial results growth rate 11.4% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (-5.6%)
  • Dividend yield for the last twelve months 0.6%
  • Free cash flow yield 0.5% (LTM)
  • Share price is 26.7% higher than minimum and 21.2% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (32.9x vs
    )
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $235.1 mln (-0.149% of cap.)

Key Financials (Download financials)

Ticker: DHR
Share price, USD:  (+0.4%)221.295
year average price 208.57  


year start price 230.84 2024-11-19

max close price 245.80 2025-01-24

min close price 174.64 2025-04-08

current price 220.44 2025-11-18
Common stocks: 727 076 992

Dividend Yield:  0.6%
FCF Yield LTM: 0.5%
EV / LTM EBITDA: 32.9x
EV / EBITDA annualized: 32.7x
Last revenue growth (y/y):  +4.4%
Last growth of EBITDA (y/y):  +18.3%
Historical revenue growth:  +0.4%
Historical growth of EBITDA:  -11.7%
Target EV / EBITDA (hist percentile):
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 160 899
Net Debt ($m): 15 337
EV (Enterprise Value): 176 236
EBITDA LTM ($m): 5 355
EV / LTM EBITDA: 32.9x
Price to Book: 3.1x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-11-11prnewswire.com

Danaher to Present at Jefferies Global Healthcare Conference

2025-10-26globenewswire.com

DHR Announcement: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

2025-10-23globenewswire.com

DHR Announcement: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

2025-10-22seekingalpha.com

Danaher: Regaining Growth Momentum

2025-10-22seekingalpha.com

Danaher Still A Hold: Good Q3 Results Alone Don't Make A Great Investment

2025-10-21prnewswire.com

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR

2025-10-21fool.com

Here's Why Shares in Danaher Got Boosted Higher Today

2025-10-21zacks.com

Danaher Q3 Earnings Beat Estimates, Life Sciences Sales Up Y/Y

2025-10-21seekingalpha.com

Danaher Corporation (DHR) Q3 2025 Earnings Call Transcript

2025-10-21zacks.com

Danaher (DHR) Q3 Earnings and Revenues Beat Estimates
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data